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MTT test was performed. Apoptotic cells were stained with Hoechst-33258 dye.
Cytoskeleton rearrangement was stained with FICT-labeled phalloidin. Intracellular
ROS production was measured using dichlorofluorescein CM-DCFA. The reduced
glutathione to oxidized glutathione ratio (GSH/GSSG) contents was measured
according to the OPT fluorimetric assay.
Results: D3R (10 -9 M) significantly increases viability of MC3T3-E1 cells and
promotes osteoblast differentiation by increasing the expression of type I collagen,
alkaline phosphatase and osteocalcin. Pre-treatment with D3R (10-9 M) significantly
prevented t-BHP-induced osteoblastic dysfunction and changes in the cytoskeleton
organization by decreasing intracellular ROS and preventing the reduction in
GSH/GSSG. D3R did not significantly modify the expression of
Osteoprotegerin/RANKL system activated by t-BHP suggesting a lack of effect of D3R
on osteoblast/osteoclast crosstalk. D3R protective effects against t-BHP-induced
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osteoblastic dysfunction were mediated by the PI3K/Akt pathway since they were
completely prevented by LY294002, a PI3K/Akt specific inhibitor.
Conclusions: these findings indicate that D3R protects MC3T3-E1 cells from oxidative
damage and suggest the potential utility of dietary D3R supplement to prevent
osteoblast dysfunction in age-related osteoporosis.
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ABSTRACT 28 
Purpose: increasing evidence suggests the potential use of natural antioxidant compounds in the 29 
prevention/treatment of osteoporosis. This study was undertaken to investigate the effects of 30 
purified delphinidin-3-rutinoside (D3R), isolated from Solanum melongena L., on osteoblast 31 
viability and differentiation in basal conditions and its ability to protect MC3T3-E1 cells against 32 
oxidative damage induced by tert-butyl hydroperoxide (t-BHP). 33 
Methods: MC3T3-E1 osteoblastic cells were treated with D3R (10-11-10- 5 M for 24 hours), 34 
followed by treatment with t-BHP (250 µM for 3 hours). To test cell viability, MTT test was 35 
performed. Apoptotic cells were stained with Hoechst-33258 dye. Cytoskeleton rearrangement was 36 
stained with FICT-labeled phalloidin. Intracellular ROS production was measured using 37 
dichlorofluorescein CM-DCFA. The reduced glutathione to oxidized glutathione ratio (GSH/GSSG) 38 
contents was measured according to the OPT fluorimetric assay. 39 
Results: D3R (10 -9 M) significantly increases viability of MC3T3-E1 cells and promotes osteoblast 40 
differentiation by increasing the expression of type I collagen, alkaline phosphatase and osteocalcin. 41 
Pre-treatment with D3R (10-9 M) significantly prevented t-BHP-induced osteoblastic dysfunction 42 
and changes in the cytoskeleton organization by decreasing intracellular ROS and preventing the 43 
reduction in GSH/GSSG. D3R did not significantly modify the expression of 44 
Osteoprotegerin/RANKL system activated by t-BHP suggesting a lack of effect of D3R on 45 
osteoblast/osteoclast crosstalk. D3R protective effects against t-BHP-induced osteoblastic 46 
dysfunction were mediated by the PI3K/Akt pathway since they were completely prevented by 47 
LY294002, a PI3K/Akt specific inhibitor.  48 
Conclusions: these findings indicate that D3R protects MC3T3-E1 cells from oxidative damage 49 
and suggest the potential utility of dietary D3R supplement to prevent osteoblast dysfunction in 50 
age-related osteoporosis. 51 
INTRODUCTION 52 
Progressive free radical damage is considered a key component in the tissue degeneration 53 
associated with aging, and the skeleton is no exception [1]. The levels of reactive oxygen species 54 
(ROS) in bone increased with age and sex steroids deficiency [2], and a correlation has been 55 
reported between oxidative stress and a decrease in bone mineral density both in aged men and 56 
women [3,4]. Furthermore, elderly osteoporotic patients displayed a marked reduction in plasma 57 
antioxidants [5]. At cellular level, oxidative stress decreases osteoblast and osteocyte lifespan and 58 
inhibits osteoblast formation suggesting a harmful role for ROS in the imbalance between bone 59 
resorption by osteoclasts and new bone deposition by osteoblasts that characterize the age-related 60 
osteoporosis. Antioxidant compounds have been proposed as attractive agents for the prevention 61 
and treatment of osteoporosis. Interestingly, parathyroid hormone (PTH), which is a strong anabolic 62 
compound, attenuates oxidative stress suggesting that antioxidant properties of PTH might 63 
contribute to its efficacy in treating age-related osteoporosis [6] A great deal of interest has been 64 
expressed towards the benefits of a diet rich in plant-based food for several chronic diseases 65 
including osteoporosis [7]. These foods are rich and exclusive sources of natural antioxidant 66 
compounds which could be responsible for their ability to attenuate age-related bone loss. 67 
Experimental studies have shown skeletal benefits of isolated nutrients such as flavonoids, 68 
lycopene, resveratrol [8,9] and anthocyanins [10]. Furthermore, dietary antioxidant intake seems to 69 
exert a beneficial effect on bone metabolism and mineral density in postmenopausal women [11,12]  70 
At cellular level, ROS increase osteoclast number [13,14] and decreased bone formation by 71 
reducing the generation and survival of osteoblasts and osteocytes, former osteoblasts that are 72 
entombed in the mineralized matrix and are responsible for sensing and adapting bone to 73 
mechanical loading [2,15,16]. Aubergine (Solanum melongena L.) fruit has been ranked among the 74 
top 10 vegetables in terms of radical oxygen absorbance capacity [17] and has been tested for its 75 
possible health promoting actions [18] . 76 
Among the various part of aubergine (entire fruit, pulp, skin), peeled skin  possess the highest 77 
capacity in the scavenging of superoxide radicals and contains the exclusive amount of anthocyanin 78 
pigments [19] such as delphinidin-3-rutinoside (D3R), and trans- and cis-delphinine 3-(p-79 
coumaroylrutinoside)-5-glucoside (nasunin,) [20].  80 
In our previous studies we have shown that nasunin, extracted and purified from aubergine peel of 81 
Japanese-type cultivars, exerts a strong protective effect against tert-butyl hydroperoxide (t-BHP)-82 
induced oxidative damage in MC3T3-E1 osteoblastic cells and prevented t-BHP-induced 83 
osteoblastic dysfunction [21]. However, the structure requirements of nasunin in relation to its 84 
protective effect against oxidative damage in MC3T3-E1 cells remains to be clarified. 85 
Previous studies on several cell types reported that the direct ability of anthocyanins to scavenge 86 
free radicals could be related to the -OH moieties on the B ring, in particular to its catechol 87 
function, to the number of OH-moieties in total [22] or to the type and extent of glycosylation and 88 
acylation [23, 24]. In the present study, we examined the effects of purified D3R, the major 89 
anthocyanin component of the aubergine skin in non-Japanese type which is a simpler delphinidin 90 
derivative than nasunin [20, 25], on MC3T3-E1 cells viability and differentiation in basal 91 
conditions. We used MC3T3-E1 osteoblast-like cell line which is the most commonly used model 92 
to study osteogenic development since the cells are characterized by distinct proliferative and 93 
differentiated stages, thus reproducing a temporal program of osteoblast differentiation as occurs 94 
during in vivo bone formation [26]. On the basis of the results obtained showing a positive effect of 95 
D3R on osteoblast differentiation, we studied the ability of D3R to counteract the cytotoxicity 96 
induced by t-BHP damage in both pre osteoblast MC3T3-E1 cells and differentiated cells and the 97 
cellular pathways involved in D3R protective effects.  98 
It is well known that cells of the osteoblastic lineage exert a physiological control of osteoclast 99 
formation and activity [27, 28] which involves both the osteoclast stimulus Receptor Activator of 100 
NFB Ligand (RANKL) and inhibition of this by the decoy receptor osteoprotegerin (OPG). Since, 101 
under stress conditions, RANKL levels exceed OPG production [29], we evaluated whether or not 102 
D3R might modulate the expression of OPG/RANKL mRNA in MC3T3-E1 cells.  103 
MATERIALS AND METHODS 104 
D3R purification and crystallization  105 
Several genotypes of non-Japanese aubergine, characterized by long and dark-purple fruit 106 
containing the anthocyanin D3R in the peel, were conventionally grown in 2011 in an experimental 107 
field at CREA-Unità di Ricerca per l’Orticoltura, located in Montanaso Lombardo (Lodi, Italy). 108 
About 50 kg of fruits were harvested at the commercial ripening stage from 5 plants/genotypes, then 109 
carefully peeled, obtaining about 2 kg of peels containing D3R. Peels were immediately frozen in 110 
an air-blast tunnel at -50 °C, then freeze-dried and ground. Freeze-dried powder was sieved through 111 
a 1 mm diameter sieve, and stored at -20 °C up to analyses. 112 
For the pigment extraction, 10 g of powder were added with 500 mL of 0.03N HCl and vigorously 113 
stirred for one hour at room temperature. The mixture was then centrifuged at 25000 × g at 4 °C for 114 
20 min and the supernatant was filtered on glass wool. The supernatant, representing the aubergine 115 
peel acidic aqueous extract, was divided into aliquots of 50 mL each and stored at -80 °C until use. 116 
For the pigment purification, the aliquots of acidic aqueous extract were treated with 50 mL of ethyl 117 
acetate in order to remove chlorogenic acid, the main phenolic in aubergine, and the two phases 118 
were carefully decanted into a separatory funnel and separated. The extraction was repeated three 119 
times. A total of 150 mL of ethyl acetate was sufficient to almost completely eliminate chlorogenic 120 
acid. 121 
The red-violet pigmented fraction, mainly containing the anthocyanin, remained in the aqueous 122 
phase. The aqueous phase was evaporated in vacuo at 40 °C to eliminate residuals of ethyl acetate, 123 
and drawn to the initial volume with water. 124 
Aqueous acidified extract from peels was further purified to obtain pure D3R-crystals following the 125 
methodology by Noda et al [30] with some modifications. 126 
The acidic aqueous chlorogenic-free extract was purified by elution on a RP18 silica gel column, 127 
32-63 mesh, 60A (ICN Biomedicals; Eschwege, Germany), previously conditioned with 0.03 M 128 
HCl (3 × 20 mL), with a ratio extract vs. resin 1:10, v/w, and eluted with MeOH (3 × 10 mL). 129 
The MeOH was carefully evaporated in vacuo to a small volume and treated with 20 mL of diethyl 130 
ether (Et2O). The mixture, showing an initial precipitate, was rapidly cooled to 4 °C and centrifuged 131 
at 3000 × g, to obtain a visible crystals precipitate of D3R. 132 
The Et2O phase was then carefully removed and the precipitate was washed with cold Et2O (3 × 5 133 
mL). After removing the solvent, D3R-crystals were dried under a stream of nitrogen flush and then 134 
stored in dark bottles at room temperature with silica gel as desiccant. The purity of D3R-crystals 135 
was checked by HPLC analysis and by 1H-NMR analysis, according to Braga et al [31, see 136 
supplementary data] 137 
Cell culture  138 
Mouse MC3T3-E1 pre-osteoblastic cells (ATCC catalog number CRL-2593), were cultured in 139 
Dulbecco’s Modified Eagle’s Medium High Glucose (D-MEM, Euroclone, Pero, Italy), 140 
supplemented with 10% foetal bovine serum (FBS, Sigma-Aldrich, Milano, Italy), 1% L-glutamine, 141 
100 µg/ml streptomycin and 100 U/ml penicillin at 37 °C in 5% CO2 atmosphere. This basic 142 
medium was changed every 3 days and cells were subcultured weekly. To study MC3T3-E1 143 
differentiation, cells were cultured in medium supplemented with L-ascorbic acid 50 µg/ml and β-144 
glycerolphosphate (10 mM, both reagents from Sigma-Aldrich). Cultures were maintained for 7 145 
days before experiments. Cells were pre-treated with D3R for 24 h before the experiments. 146 
Citotoxicity assay  147 
Cells were plated at the density of 3x103 cells/ in a 96-well culture plate. After treatment with D3R, 148 
cells were washed with phosphate buffered saline (PBS, Euroclone, Pero, Italy) and incubated at 37 149 
°C with 0.5 mg/ml 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazoliumbromide (MTT, Sigma-150 
Aldrich) for 3 h. The conversion of the tetrazolium salt MTT to a colored formazan was used to 151 
assess cell viability. After the supernatant was removed, dimethyl sulphoxide (DMSO) was added 152 
to each well and the absorbance was recorded by a microplate spectrophotomer (WALLAC, Victor 153 
2, PerkinElmer, Waltham, MA, USA) at 550 nm. Cell phenotypic observations were made using 154 
Olympus TH4-200 inverted phase-contrast microscope, fitted with a digital camera Olympus C-155 
4040 zoom to record any change during treatment. 156 
Induction of oxidative stress 157 
Oxidative stress was induced by tert-butyl hydroperoxide (t-BHP, Sigma-Aldrich, 250 µM for 3 h) 158 
and by antimycin A (AMA, Sigma-Aldrich, 70 µM for 24 h). After 24 h preincubation time, D3R 159 
was completely removed and the medium was exchanged before adding t-BHP or AMA. This 160 
avoided a direct interaction between D3R and the oxidative source in the medium. Pre-treatment 161 
with LY294002 (Sigma-Aldrich, 10 µM), an inhibitor of PI3K/Akt pathway, was performed 1 h 162 
before D3R. 163 
Hoechst staining of apoptotic cells 164 
Morphological changes in the nuclear chromatin of apoptotic cells were detected by Hoechst-33258 165 
(Sigma-Aldrich) staining. MC3T3-E1 cells (5x103 cells/well) were grown on 22-mm glass 166 
coverslips in 6-well plates. After treatments, the cells were fixed with 4% formaldehyde in 0.12 M 167 
sucrose, permeabilized with 0.1% TritonX100 in PBS for 5 min, and stained with 10 μg/ml 168 
Hoechst-33258 DNA dye for 5 min. The cells then visualized using an Axioplan fluorescence 169 
microscope. The blue fluorescent Hoechst 33258 is a cell permeable nucleic acid dye usually used 170 
to identify chromatin condensation and fragmentation by staining the condensed nuclei of apoptotic 171 
cells. Uniformly stained nuclei were scored as healthy, viable cells. Condensed or fragmented 172 
nuclei were considered as apoptotic. At least 200 cells were scored blindly without knowledge of 173 
their prior treatment. 174 
Cytoskeleton rearrangement  175 
MC3T3-E1 cell growth, fixation and permeabilization were carried out by the same procedure as 176 
mentioned above. The permeabilized cells were incubated with FITC-labeled phalloidin (diluted 177 
1:100 in PBS) for 20 min at room temperature and mounted in Vectashield Mard Set Mounting 178 
Medium with 4’, 6-diamidino-2-phenylindole (DAPI, Vector Laboratories, Burlingame, CA, USA). 179 
The images were obtained using an Axioplan fluorescence microscope. 180 
Alkaline phosphatase (ALP) activity and collagen content 181 
MC3T3-E1 cells were seeded at the density of 1x104 in 48-well plates and treated as previously 182 
described in the section 2.2. After 6 days the cells were cultured with a medium containing 1% FBS 183 
and D3R (10-9 M) for 24 h followed by treatment with t-BHP (125 for 3h). After  t-BHP was 184 
washed out with fresh medium,   cells were incubated with D3R for 24 or 48 h to measure ALP or 185 
collagen content, respectively.  186 
On harvesting, the medium was removed and cell monolayer gently washed twice with PBS. The 187 
cells were lysed with 0, 2% Triton-X-100 and centrifuged at 14,000 × g for 10 min. The clear 188 
supernatant was used to measure the ALP activity and protein concentration with  a commercially 189 
available ALP activity assay kit (Sigma-Aldrich) and BCA-protein assay kit (Thermo-Fisher 190 
Sientific, SpA, Rodano, Italy) respectively. ALP activity was measured as nmol/min/mg prot and 191 
results were expressed as percentage of differentiated controls.  192 
Collagen content was quantified by Sirius Red-based colorimetric assay as previously described 193 
[21]. Cultured osteoblasts were washed with PBS, followed by fixation with Bouin’s fluid for 1h. 194 
After fixation the culture dishes were washed by immersion in running tap water for 15 min, air 195 
dried and stained by Sirius red dye reagent (Sigma-Aldrich) for 1h under mild shaking. The solution 196 
was removed and culture washed with 0.01 M HCl. Subsequently, the stained material was 197 
dissolved in 0.1 M NaOH and absorbance read at 550 nm. The results are expressed as percentage 198 
of differentiated control absorbance.   199 
Intracellular ROS production 200 
ROS production was measured using 5(6)-carboxy-2’, 7-dichlorofluorescin diacetate (CM-DCFA, 201 
Sigma-Aldrich, 10 M) as previously described [32]. The MC3T3–E1 cells were seeded in black 202 
96-well plates and cultured for 24 h. On the day of the experiment, the cells were pre-incubated 203 
with D3R (10-9 M) for 24h and loaded with CM-DCFA during the last 30 min of treatment. After 204 
CM-DCFA was removed, the cells were exposed to t-BHP (250 M) for 3h. DCF fluorescence was 205 
assessed with a spectrofluorophotometer (Victor™, PerkinElmer) at the excitation (485 nm) and 206 
emission (530 nm) wavelength. 207 
Measurement of cell glutathione and glutathione disulphide levels 208 
The intracellular content of glutathione (GSH) and glutathione disulphide (GSSG) was measured 209 
after t-BHP (250 µM for 3h) according to the o-phthalaldehyde (OPT) fluorimetric assay as 210 
previously described [21]. Alteration in the GHS/GSSG ratio was used to assess the exposure of 211 
cells to oxidative stress. At pH 8, OPT conjugates with GSH and produces fluorescence that is 212 
proportional to the concentration of GSH in the sample. At pH 12 and in the presence of N-213 
ethylmaleimide (NEM), OPT will conjugate only with GSSG and not GSH. Fluorescence was read 214 
at 420 nm with excitation set at 350 nm. The concentration was calculated from a standard curve 215 
using serial dilutions of GSH or GSSG and normalized to protein concentration measured by BCA 216 
assay. 217 
Quantitative PCR 218 
To investigate the effects of D3R on the expression of genes involved in osteoblasts differentiation 219 
and bone remodeling, MC3T3-E1 cells (1.5 × 105 cells/well) were plated in 6-well plates, 220 
differentiated as previously described and treated with D3R (10-9 M) or medium without the test 221 
agent for 24 h. Adherent cells were harvested and total RNA was extracted using TRIzol according 222 
to the manufacturer’s instructions (Invitrogen Life Technology, Inc., Paisley, UK). RNA pellet 223 
concentrations were assessed spectrophotometrically using microcuvette G1.0 in Eppendorf 224 
Biopohotometer. The absorbance spectrum was checked for each sample in Eppendorf 225 
Biopohotometer. Specific sets of primers for ALP, collagen type 1, alpha 1 (ColA1), osteocalcin 226 
(OC), OPG and RANKL. -catenin cDNAs were designed and synthesized (Sigma-Aldrich), 227 
according to Zhang et al. [33] and Dong et al. [34]. Quantitative PCR was performed in CFX96 228 
Bio-Rad using 20 μl of total volume. The efficiency of each set of primers was evaluated in 229 
preliminary experiments and it was found close to 100% for target and for the housekeeping gene 230 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Total RNA (800 ng) was retrotranscribed 231 
using the IScript Supermix kit (Bio-Rad), according to the manufacturer’s protocol. The 232 
amplification was carried out on 5 ng of total cDNA using SYBR chemistry (iTAQ Universal 233 
SYBR green supermix, Bio-Rad) according to the manufacturer’s protocol. Real-time PCR was run 234 
according to the following protocol: an initial step of 30 sec at 95 °C followed by 40 cycles of 5 sec 235 
at 95 °C and 30 sec at 60 °C. A dissociation stage with a melt curve analysis was also performed. 236 
Four replicates were performed for each experimental point and experiments were repeated four 237 
times. Gene expression was quantified using the comparative threshold-cycle (DDCt) method 238 
considering that the targets and the reference genes have the same amplification efficiency (near to 239 
100%). 240 
Statistical analysis 241 
Statistical analysis was performed with a statistic package (GraphPad Prism5, GraphPad Software 242 
San Diego, CA, USA). All data are represented as the mean ± SEM of four independent 243 
experiments. Differences between groups were assessed by one-way analysis of variance (ANOVA) 244 
followed by Bonferroni test when data were parametric. Non-parametric data were analyzed by a 245 
Kruskal-Wallis test followed by Dunn’s test. Differences with a p<0.05 were considered to be 246 
significant. 247 
RESULTS 248 
Effect of D3R on MC3T3-E1 cell viability: 249 
We first examined the effect of increasing D3R concentrations on MC3T3-E1 cell viability in basal 250 
conditions using MTT test.  As shown in Fig.1, D3R induces a slight increase in cell viability which 251 
reached statistical significance (13% vs controls) at 10-9 M and D3R (10-9 M) was chosen for further 252 
experiments on differentiated cells. 253 
Effect of D3R on differentiated MC3T3-E1 cells 254 
D3R (10-9 M) did not significantly modify osteoblast viability in differentiated cells (data not 255 
shown) but stimulates the expression of several genes involved in osteoblast differentiation 256 
determined using real time PCR assay. D3R treatment resulted in a significant increased expression 257 
of ALP and Col1A1, considered early-stage osteogenic differentiation markers, and of OC, a late-258 
marker of differentiation (Fig. 2a). qPCR data fit well with the stimulatory action of D3R on ALP 259 
activity and collagen content (Fig. 2b). When we examined the effects of D3R on the OPG/RANKL 260 
system, the main regulator of osteoclast differentiation and activation we found a slight, but not 261 
significant increase in the expression of OPG without any effect on RANKL. The effects of D3R on 262 
osteoblast differentiation could be due to activation of the Wnt/β-catenin signaling pathway since 263 
D3R up-regulated the mRNA expression of β-catenin (Fig. 2a) and it is well known that ALP and 264 
OC are β-catenin target genes. 265 
Effect of D3R on t-BHP-induced cytotoxicity in MC3T3-E1 cells 266 
To study whether D3R would protect MC3T3-E1 cells against oxidative damage, we treated cells 267 
with increasing D3R concentrations (10 -5 – 10 -11 M) 24 h before t-BHP (250 M for 3 h), a 268 
cytotoxic organic hydroperoxide used in our previous studies [21, 31] to induce oxidative damage.  269 
As expected, t-BHP significantly reduced MC3T3-E1 cell viability of 30 %, as compared with 270 
control group as assessed by the MTT test. Pretreatment with D3R significantly reduced the 271 
oxidative damage induced by t-BHP with a maximal protective action at 10-9 M (Fig. 3a). Similar 272 
results were obtained when we examined the ability of D3R to counteract cytotoxicity induced by 273 
AMA which generates ROS by inhibiting the mitochondrial electron transport chain complex III 274 
(Fig 3b). When we examined the effect of D3R on t-BHP-induced apoptosis, we found that 275 
pretreatment (24 h before) with 10-9 M D3R significantly reduced t-BHP (250 M, for 3 h)-induced 276 
cell apoptosis (Fig. 4b). The protective action of D3R against typical nuclear changes associated 277 
with cell apoptosis induced by t-BHP is reported in Fig. 4a. 278 
Since cytoskeleton changes could be considered as a powerful tool to study cell apoptotic death in 279 
osteoblasts, we studied the effect of pretreatment with D3R on t-BHP-induced morphological 280 
changes in MC3T3-E1 cells by examining the arrangement of the actin fibres with Phalloidin-FITC. 281 
As shown in Fig. 5, untreated MC3T3-E1 cells have a well-organized cytoskeleton with actin 282 
microfilaments placed in the direction of their main axis. D3R did not modify normal cytoskeletal 283 
morphology but prevented the MC3T3-E1 shape modification and the rearrangement of the actin 284 
network observed in the presence of t-BHP. 285 
Effect of D3R on ROS levels and detoxifying system 286 
The significant increase in the intracellular ROS levels induced by t-BHP was prevented by D3R 287 
treatment. In D3R-treated cells, in fact, ROS levels were similar to those detected in control-treated 288 
cells (Fig. 6a). It is well known that ROS-mediated apoptotic signalling is associated with decreased 289 
cellular GSH levels and loss of cellular redox balance. When MC3T3-E1 cells were treated with t-290 
BHP almost 60% reduction in GSH/GSSG ratio occurred (Fig. 6d) due to a decrease in GSH (Fig. 291 
6b) and an increase in GSSG (Fig. 6c) levels. D3R treatment significantly reduced GSSG levels and 292 
prevented the reduction in GSH/GSSG ratio which remained similar to that detected in control-293 
treated MC3T3-E1 cells. 294 
Inhibition of PI3K/Akt pathway block the protective effect of D3R 295 
To study the involvement of PI3K/Akt  in the D3R-mediated protection against oxidative damage, 296 
we pre-treated MC3T3-E1 cells with LY294002, a PI3K/Akt specific inhibitor. As shown in Fig. 7, 297 
LY294002 (10 µM, 1h before D3R) worsened t-BHP  cytotoxicity and the completely removed the 298 
protective action of D3R against t-BHP-induced oxidative damage.  299 
Effect of D3R on t-BHP-induced cytotoxicity in differentiated MC3T3-E1 cells 300 
To ascertain whether D3R is able to prevent MC3T3-E1 dysfunction induced by t-BHP, MC3T3-E1 301 
cells were cultured in differentiation-inducing medium, as described in Material and Methods 302 
section. Differentiated cells were incubated with D3R (10-9 M) 24 h before t-BHP challenge. We 303 
used t-BHP 125 M, for 3 h, since differentiated MC3T3-E1 cells were more sensitive to damage 304 
than their undifferentiated counterparts (data not shown). t-BHP significantly reduced both collagen 305 
content (31%) and ALP activity (55%) as compared with control-treated cells. Pre-treatment with 306 
D3R significantly protects against t-BHP-induced cytotoxicity being collagen and ALP activity 307 
significantly higher than those detected in  t-BHP-treated cells (Fig. 8). 308 
Effect of D3R on t-BHP-induced RANKL expression 309 
As expected, treatment with t-BHP induced a strong reduction in the expression of OPG and a 310 
significant increase in the expression of RANKL. Pre-treatment with D3R failed to modify the 311 
action of t-BHP on mRNA levels of OPG and RANKL and did not reverse the relative ratio of OPG 312 
to RANKL, considered the critical determinant in the regulation of osteoclast biology (Fig.9). 313 
DISCUSSION 314 
In the present study we have showed that purified aubergine skin extracts of D3R, are able to induce 315 
osteoblast viability and osteogenic differentiation in basal conditions and to protect MC3T3-E1 316 
cells against oxidative damage induced by two different compounds: t-BHP, and AMA. The organic 317 
hydroperoxide t-BHP generates reactive intermediates within cells which damage several 318 
biomolecules including lipids, thiols, DNA and proteins [35]. AMA generates ROS by inhibiting 319 
the mitochondrial electron transport chain complex III [36] 320 
The positive action of D3R on osteoblast activity could be due to an increased expression of 321 
osteoblast differentiation markers such as ALP, Col1A1 and OC probably linked to an activation of 322 
the Wnt/β catenin signalling pathway. 323 
Incubation of MC3T3-E1 cells with t-BHP induced a significant increase in ROS generation leading 324 
to reduced cells viability and apoptotic cell death. D3R treatment reduced intracellular ROS levels 325 
and prevented redox state alteration induced by t-BHP by increasing GSH. We also found that 326 
PI3K/Akt pathway is involved in the protective effect of D3R against t-BHP cytotoxicity since it is 327 
removed by pre-treatment with LY294002 a specific PI3K/Akt inhibitor. 328 
When we examined the ability of D3R to modulate osteoblast/ osteoclast crosstalk, we found a lack 329 
of effect of D3R on the expression of OPG/RANKL system activated by t-BHP. 330 
Osteoblasts play a pivotal role in bone formation which involves osteoblast proliferation, 331 
differentiation and mineralization [37]. The process of osteoblast differentiation is characterized by 332 
a series of temporally and spatially coordinated events. 333 
In the early stage, cells proliferate and the matrix matures. ALP is considered an early phenotypic 334 
marker of osteoblastogenesis [38]. ALP hydrolysed a variety of phosphate components releasing 335 
inorganic phosphate into the extracellular matrix [39]. OC a late-marker of differentiation can bind 336 
Ca2+ to regulate calcium ion homeostasis and bone mineralization [40]. Collagen type I is a 337 
necessary initiator in MC3T3-E1 cell differentiation and a required substrate for matrix 338 
mineralization [41]. D3R increased the expression of ALP, OC and Col1A1 suggesting that D3R is 339 
able to stimulate osteoblast differentiation from the early to the terminal stage, up-regulating both 340 
maturation and differentiation of MC3T3-E1 cells. 341 
The Wnt/β-catenin signalling pathway is one of the most important regulators of osteoblast 342 
proliferation, differentiation and mineralization [42]. Targeting components of such pathway will 343 
influence bone formation and could have clinical applications including improving 344 
osteoblastogenesis in osteoporosis. 345 
Wnt canonical signalling pathway relies on the cytosolic stabilization of β-catenin, which is a 130 346 
amino acid protein that, in the absence of Wnt proteins, is phosphorylated by a glycogen synthase 347 
kinase (GSK-3 β) and degraded by the proteosomal machinery. Activation of the canonical Wnt 348 
signalling by Wnt proteins prevents the proteasomal degradation of β-catenin and promotes its 349 
association with TCF/Lef family of transcription factors and the expression of Wnt target genes 350 
[43]. Wnt/β-catenin signalling pathway can induce in MC3T3-E1 cells several osteoblast 351 
differentiation markers including ALP and collagen [44, 45]. We can only speculate that D3R could 352 
increase osteoblast differentiation by activating the Wnt/β-catenin signalling pathway, since we 353 
have only data regarding the D3R-induced upregulation of β-catenin mRNA and not β-catenin 354 
protein levels. This is a limitation of our study since it has been reported that the amount of β-355 
catenin protein levels depends on the state of β-catenin destruction complex rather than the 356 
expression of β-catenin mRNA [46]. Considering the complexity of the Wnt/ β-catenin signalling 357 
pathway, further studies will be required to examine the effects of D3R on β-catenin protein levels 358 
both in the cytoplasm and in the nucleus and its ability to inactivate the destruction complex leading 359 
to GSK-3β phosphorylation and inactivation.  360 
The potential utility of D3R as promoter of bone formation was further investigated in condition of 361 
oxidative stress. Several epidemiological evidence in humans and experimental studies in rodents 362 
indicate that oxidative stress induced by ROS, plays an important role in the development of 363 
osteoporosis [2]. ROS, in fact, have been reported to impair osteoblast activity and to contribute to 364 
the negative skeletal balance occurring during aging.  365 
In the present study, we have shown that D3R protects MC3T3-E1 osteoblastic like cells from t-366 
BHP-induced cytotoxicity by preventing cell death and apoptosis as shown by MTT assay and 367 
Hoechst 33258 staining. Furthermore, D3R prevented the negative effects of t-BHP on osteoblastic 368 
function and recovered its changes in the cytoskeleton organization characterized by actin fibres 369 
destruction [32]. D3R exerts its protective effect against t-BHP-induced oxidative damage by 370 
reducing intracellular ROS and increasing intracellular antioxidant factors such as glutathione. GSH 371 
is an important intracellular antioxidant and redox potential regulator that functions by scavenging 372 
free radicals and converted itself to its oxidized form GSSG, thus protecting cells from oxidative 373 
stress [47].  374 
t-BHP-treated cells showed an impairment of cellular glutathione redox status with a decrease in 375 
GSH levels along with the increase in its metabolite GSSG. Pretreatment with D3R prevented this 376 
alteration and GHS redox status was maintained to a level comparable to that detected in control-377 
treated MC3T3-E1 cells. To investigate the cellular pathways involved in D3R protection against 378 
oxidative stress we explore the possible involvement of the PI3K/Akt  pathway which is implicated 379 
in the growth and survival of a range of cell types including osteoblasts [48] and participates to the 380 
prevention of oxidative stress-induced apoptosis [49]. 381 
We found that inhibition of PI3K/Akt pathway by LY294002 completely removed the protective 382 
effect of D3R against t-BHP-induced oxidative damage. Further studies will be required to clarify 383 
the Akt survival signals activated by D3R in MC3T3-E1 cells. The PI3K/Akt signalling pathway, in 384 
fact, plays a crucial role in the control of cell survival due to its direct capacity to activate several 385 
signalling molecules or to cross-talk with other signalling pathways and transcriptional networks. 386 
PI3K/Akt signalling is involved in Nrf2-dependent transcription, and Nrf2 regulates the expression 387 
of antioxidant genes including GSH. PI3K/Akt can also regulates not only down-stream effectors 388 
such Bcl-2 family proteins which play an important anti apoptotic role [50] but also the canonical 389 
Wnt signalling pathway by inhibiting the phosphorylation of GSK-3β thus resulting in the 390 
activation of. β-catenin [51, 52]. Furthermore, Akt has been reported to increase β-catenin 391 
transcriptional capacity due to a direct ability of Akt to phosphorylate β-catenin [53]. It is possible 392 
that the protective effect of D3R against oxidative damage could involve, at least in part, the 393 
PI3K/Akt and β-catenin pathways, since preliminary data indicate that the increased expression of 394 
β-catenin mRNA induced by D3R was prevented by LY294002 (data not shown). 395 
As previously reported [54] differentiated MC3T3-E1 osteoblast like cells show greater sensitivity 396 
to ROS than their undifferentiated counterpart. These findings support the possibility that in normal 397 
or pathological aging, osteoblasts potentially become more vulnerable to ROS levels as they 398 
mature, which could explain the reason why older people are more likely to suffer bone fractures. 399 
The evidence that D3R significantly prevented the toxic effect of t-BHP on collagen content and 400 
ALP activity indicate that D3R could represent an interesting approach in the management of 401 
osteoblastic dysfunction associated with increased oxidative stress. 402 
As far as the influence of anthocyanin chemical structures in relation to their cellular antioxidant 403 
activities is concerned, previous studies have shown that the radical scavenging activity of 404 
anthocyanins are correlated with the largest number of hydroxyl groups in B ring [55] and is 405 
influenced by the glycosylation pattern [24]. Previous studies have reported a higher scavenging 406 
activity of nasunin compared with D3R by using t-BHP as a free radical initiator [56] and the 407 
oxidative burst of human polymorphonuclear neutrophils [31]. In the present study on MC3T3-E1 408 
cells, we found that the protective action of D3R against t-BHP-induced oxidative damage is 409 
comparable, in terms of potency, with that previously reported for nasunin [21]. Both purified 410 
functional food components, in fact, exert their maximum effect at 10-9 M, suggesting that their 411 
ability to protect cells against oxidative damage is independent from their glycosylation pattern 412 
constituted by simple 3-rutinose in D3R, with the addition of a glucose in 5-position and of a 413 
coumaryl moiety linked to rutinose in nasunin. A possible explanation for these discrepancies could 414 
be due to the experimental protocol used in our experimental protocol showing an indirect 415 
antioxidant activity of both D3R and nasunin via increased expression/activity of defence 416 
mechanisms such GSH instead of a direct scavenging activity. 417 
It is well known that ROS increase osteoclast number and activity and that reduced antioxidant 418 
defence in postmenopausal women is associated with bone loss [2]. Several antioxidant functional 419 
food compounds such as flavonoids, terpenoids and polyphenols have been reported to inhibit 420 
osteoclastogenesis via regulating many factors involved in the process of osteoclast differentiation 421 
and maturation including transcription factors (NFATc1, c-Fos), signalling pathways such as NF-422 
B, MAPKs and PI3K/Akt [57] and OPG/RANKL system [58]. 423 
RANKL and OPG synthetized by osteoblasts. RANKL plays a critical role in stimulation of 424 
osteoclast differentiation and survival through its receptor RANK. The secretion of OPG by 425 
osteoblasts prevents RANKL/RANK interaction and results in inhibition of bone resorption. 426 
Therefore, a ratio of OPG/RANKL is considered a crucial factor for bone resorption [27]. 427 
At variance from previously reported for other functional food components [58], D3R did not 428 
significantly affect the expression of OPG and RANKL in basal conditions and did not prevent the 429 
increased expression of RANKL induced by t-BHP in MC3T3-E1 cells. We cannot rule out the 430 
possibility that D3R could be involved in osteoblast/osteoclast crosstalk for several reasons. At first, 431 
we have to confirm the lack of effect of D3R on OPG/RANKL ratio by measuring the effects of 432 
D3R on OPG and RANKL protein amount. Furthermore, considering that oxidative stress could 433 
stimulate the inflammatory reaction via activation of pro-inflammatory cytokines [59] it could be 434 
interesting to study the effects of D3R on pro-inflammatory cytokines levels which, besides 435 
OPG/RANKL, regulate the cellular events involved in the bone resorption [60]. However, to 436 
address this point, we have to plan new experiments in MC3T3-E1 cells aimed to study the effects 437 
of t-BHP (250 µM, 3h) on pro-inflammatory cytokines production and the possible effects of pre-438 
treatment with D3R. The link between t-BHP-induced oxidative damage and production of IL 6 and 439 
TNF-α has been reported only in endothelial cells [61] by using a different experimental condition 440 
(t-BHP 50 µM, 24h). Furthermore in the experiments performed by Lee and colleagues [62] 441 
showing an inhibitory activity of berry anthocyanins on IL1b and TNF-α mRNAs levels, was used a 442 
blackcurrant fraction containing D3R (44%) and cyaniding- 3 rutinoside (17%) instead of purified 443 
D3R as used in the present paper. 444 
Previous in vivo studies have shown that commercial delphinidin intake protects against 445 
ovariectomy-induced osteopenia in mice by inhibiting osteoclast activity [10]. This discrepancy 446 
could be due to different experimental conditions, and/or to the different type of anthocyanin used. 447 
Moriwaki and colleagues [10], in fact used concentrations (0.8 to 66 M) against the nM ranges 448 
used in the present experiment and examined  the direct action of delphinidin on osteoclast 449 
formation and activity instead of an indirect modulatory effect of osteoblast on osteoclast through 450 
OPG/RANKL. Furthermore, it is possible that the different behaviour of D3R and delphinidin on 451 
osteoclastogenesis could be due to their very different chemical structure, since the delphinidin is 452 
the aglycon moiety of D3R, differentiated by the presence of rutinose in 3- position. Further studies 453 
will be required to examine the effect of the lack or a different pattern of glycosylation on osteoclast 454 
function.  455 
It has to be pointed out that, often, the natural extracts obtained in optimal conditions, contain the 456 
anthocyanins in glycosylated forms, increasing their stability, with only a minor part of the 457 
respective aglycons that, if present in significant amounts, could be considered as artefacts [63].  458 
 459 
CONCLUSIONS 460 
To our best knowledge, we have provided the first evidence that D3R promotes osteoblastic 461 
function by increasing the expression of bone specific matrix proteins (ALP, OC and Col1A1) and 462 
protects MC3T3-E1 cells against t-BHP cytotoxicity via its antioxidant capacity. The D3R 463 
protective effects against t-BHP cytotoxic depend on the activation of the PI3K/Akt signalling 464 
pathway.  465 
These results suggest that purified D3R could be a potential preventive agent against oxidative 466 
damage in osteoblastic cells. As the present study was about the in vitro effects of D3R, further in 467 
vivo studies are needed to investigate the ability of dietary D3R supplement to regulate osteoblast 468 
function in bone debilitating diseases such as osteoporosis linked to increased oxidative damage. 469 
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LEGEND TO FIGURES 687 
Fig. 1 Effects of D3R (10-11-10-5 M) on cell viability measured by MTT assay 24 h after treatment.  688 
Data are expressed as the percentage relative to control and are the mean + SEM of four replicates 689 
within a single experiment.* p<0.05 vs controls 690 
Fig. 2 Effects of D3R (10-9 M) on ALP, Col1A1, OC, β-catenin, OPG and RANKL expression (a) 691 
and ALP activity and Collagen content (b). The gene expression was measured by real time PCR. 692 
Cells were treated with D3R for 24 h and mRNAs were collected. 100 ng of cDNA from each 693 
sample were amplified using the SYBR® Green Chemistry and a specific set of primers for ALP, 694 
Col1A1, OC, β-catenin, OPG and RANKL. Each sample was evaluated in triplicate. Data were 695 
normalized for GAPDH and expressed as mean ± SEM of the relative amounts of gene/GAPDH of 696 
each sample vs the mean control value. Four replicates were performed for each experimental point 697 
and the experiments were repeated twice. ALP activity and Collagen deposition were evaluated 698 
24/48 hours after treatment with D3R. * p<0.05, ** p< 0.01, ***p< 0.001 vs controls 699 
Fig. 3 Effects of D3R (10-11-10-5 M) on t-BHP (a) or AMA-induced (b) cytotoxicity in MC3T3-E1 700 
cells. Cells were preincubated with D3R 24 h before treatment with t-BHP (250 µM for 3 h) or 701 
AMA (70 µM for 24 hours). Cell viability was measured by MTT assay. Data are expressed as the 702 
percentage relative to control and are the mean + SEM of four replicates within a single experiment. 703 
*** p<0.001 vs controls; °p<0.05, °°p<0.01, °°°p< 0.0001 vs t-BHP or AMA. 704 
Fig. 4 Effects of D3R on apoptosis induced by t-BHP in MC3T3-E1 cells. Cells were pre-incubated 705 
with D3R (10-9 M) for 24 h and then treated with t-BHP (250 µM for 3 h). Apoptosis was detected 706 
by Hoechst 33258 staining. a) Panels are representative of condensed fragmented nuclei 707 
characteristic of apoptosis. Images were taken at 20x magnification. b) Quantification of apoptosis. 708 
Values are the mean + SEM of duplicate determinations (200 cells each) of four independent 709 
experiments. *** p<0.001 vs controls; °°°p<0.001 vs t-BHP. 710 
Fig. 5 Protective effects of D3R on cytoskeleton alterations induced by t-BHP in MC3T3-E1 cells. 711 
Cells were preincubated with D3R (10-9 M) 24 h before treatment with t-BHP (250 µM for 3 h). 712 
Representative images of cytoskeleton alterations evaluated with Axioplan fluorescence microscope 713 
(magnification 20x) detected by Phalloidin-FITC staining of the actin protein. 714 
Fig. 6 Protective effects of D3R on intracellular ROS generation and cellular redox imbalance 715 
induced by t-BHP in MC3T3-E1 cells. Cells were pre-incubated with D3R (10-9 M) 24 h before 716 
treatment with t-BHP (250 µM for 3 h). The intracellular ROS concentration was measured using 717 
CM-DCFA assay. Intracellular content of GSH and GSSG were measured using o-phthalaldehyde 718 
(OPT) fluorimetric assay and GSH/GSSG ratio was determined. Data are expressed as the 719 
percentage relative to control and are the mean + SEM of six replications. * p<0.05, ** p< 0.01, 720 
***p< 0.001 vs controls; °p<0.05, °° p<0.01 vs t-BHP.  721 
Fig. 7 Effects of pretreatment with LY294002, a PI3-K antagonist, on D3R protective effects 722 
against t-BHP -induced MC3T3-E1 cytotoxicity. Cells were pre-incubated with LY294002 (10μM) 723 
1h before D3R (10-9 M 24 h) and t-BHP (250 μM for 3 h) treatments. Cell viability was measured 724 
by MTT assay. Data are expressed as the percentage relative to control and are the mean + SEM of 725 
four replicates within a single experiment. a p<0.001 vs control; b p<0.001 vs t-BHP, c p<0.001 vs 726 
D3R+ t-BHP. 727 
Fig. 8 D3R (10-9 M, 24h before) prevents the t-BHP-induced decreases in ALP activity and collagen 728 
content in differentiated MC3T3-E1cells. ALP activity (a) and collagen content (b) were evaluated 729 
24 or 48h after treatment with t-BHP (125 µM for 3 h). Data are expressed as the percentage 730 
relative to control and are the mean + SEM of six replications. ***p<0.001 vs controls; °°p<0.01, 731 
°°°p<0.001 vs t-BHP.  732 
Fig. 9 Effects of D3R (10-9 M) on osteoprotegerin (OPG) and RANKL expression measured by real 733 
time PCR. Cells were pretreated with D3R for 24 h before t-BHP (250 µM for 3 h) and mRNAs 734 
were collected. 100 ng of cDNA from each sample were amplified using the SYBR® Green 735 
Chemistry and a specific set of primers for OPG and RANKL. Each sample was evaluated in 736 
triplicate. Data were normalized for GAPDH and expressed as mean ± SEM of the relative amounts 737 
(in percentage) of gene/GAPDH of each sample vs the mean control value (panel a and b). For the 738 
panel c a ratio between the OPG and RANKL expression was calculated. Four replicates were 739 
performed for each experimental point and the experiments were repeated twice. 740 
* p<0.05, ** p< 0.01, ***p< 0.001 vs controls. 741 
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